This website is for Israeli Healthcare Professionals only.

Therapy areas

AbbVie makes a difference to the health of millions of people. We specialise in researching and developing innovative products for some of the world's most serious and complex diseases. We are already providing medicines for many diseases for which the medical need is great, and the treatment options are limited. Explore our therapy areas below and see the latest information and research relating to AbbVie products and specific disease areas.

Immunology

Skyrizi 

 Indicated for the treatment of moderate to severe Plaque Psoriasis in adults who are candidates for systemic therapy or phototherapy.

Rinvoq

for the treatment of moderate to severe active Rheumatoid Arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). 

Neurology

UBRELVY

For the acute treatment of Migraine with or without aura in adults. UBRELVY is not indicated for the preventive treatment of migraine.

BOTOX

For symptom relief in adults fulfilling criteria for Chronic migraine (headaches on ≥15 days per month of which at least 8 days with migraine) in patients who have responded inadequately or are intolerant of prophylactic migraine medications.

Produodopa

For the treatment of advanced levodopa-responsive Parkinson’s disease with severe motor fluctuations and hyperkinesia or dyskinesia when available combinations of Parkinson medicinal products have not given satisfactory results.

Oncology

Tepkinly

For the treatment of adult patients with relapsed or refractory Diffuse Large B-cell Lymphoma (DLBCL), not otherwise specified, including DLBCL arising from indolent lymphoma, and high-grade B cell lymphoma after two or more lines of systemic therapy.

Eye Care

Ozurdex

For the treatment of adult patients with Diabetic macular oedema (DME) / Macular oedema following either BRVO or CRVO / Inflammation of the posterior segment of the eye presenting as non-infectious uveitis. 

Therapeutic Focus Areas